Xvivo Perfusion AB
STO:XVIVO

Watchlist Manager

Xvivo Perfusion AB

STO:XVIVO

Watchlist

Dividends

Price: 451.5 SEK 1.23% Market Closed

Market Cap: 14.2B SEK

Have any thoughts about
Xvivo Perfusion AB?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

Add Price Alert

Price Target:

Last Price: 451.5 SEK

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

XVIVO Alert

Xvivo Perfusion AB

451.5

+5.5 (+1.23%)

52 Week Range	256.5 539
Price Target

We'll email you a reminder when the closing price reaches SEK.

Save Alert

Choose the stock you wish to monitor with a price alert.

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Xvivo Perfusion AB

What unique competitive advantages
does Xvivo Perfusion AB hold over its rivals?

What risks and challenges
does Xvivo Perfusion AB face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Xvivo Perfusion AB.

What unique competitive advantages
does Xvivo Perfusion AB hold over its rivals?

What risks and challenges
does Xvivo Perfusion AB face in the near future?

Has there been any significant insider trading activity
in Xvivo Perfusion AB recently?

Summarize the latest earnings call
of Xvivo Perfusion AB.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Xvivo Perfusion AB.

Provide P/S
for Xvivo Perfusion AB.

Provide P/E
for Xvivo Perfusion AB.

Provide P/OCF
for Xvivo Perfusion AB.

Provide P/FCFE
for Xvivo Perfusion AB.

Provide P/B
for Xvivo Perfusion AB.

Provide EV/S
for Xvivo Perfusion AB.

Provide EV/GP
for Xvivo Perfusion AB.

Provide EV/EBITDA
for Xvivo Perfusion AB.

Provide EV/EBIT
for Xvivo Perfusion AB.

Provide EV/OCF
for Xvivo Perfusion AB.

Provide EV/FCFF
for Xvivo Perfusion AB.

Provide EV/IC
for Xvivo Perfusion AB.

Show me price targets
for Xvivo Perfusion AB made by professional analysts.

What are the Revenue projections
for Xvivo Perfusion AB?

How accurate were the past Revenue estimates
for Xvivo Perfusion AB?

What are the Net Income projections
for Xvivo Perfusion AB?

How accurate were the past Net Income estimates
for Xvivo Perfusion AB?

What are the EPS projections
for Xvivo Perfusion AB?

How accurate were the past EPS estimates
for Xvivo Perfusion AB?

What are the EBIT projections
for Xvivo Perfusion AB?

How accurate were the past EBIT estimates
for Xvivo Perfusion AB?

Compare the revenue forecasts
for Xvivo Perfusion AB with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Xvivo Perfusion AB and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Xvivo Perfusion AB against its competitors.

Analyze the profit margins
(gross, operating, and net) of Xvivo Perfusion AB compared to its peers.

Compare the P/E ratios
of Xvivo Perfusion AB against its peers.

Discuss the investment returns and shareholder value creation
comparing Xvivo Perfusion AB with its peers.

Analyze the financial leverage
of Xvivo Perfusion AB compared to its main competitors.

Show all profitability ratios
for Xvivo Perfusion AB.

Provide ROE
for Xvivo Perfusion AB.

Provide ROA
for Xvivo Perfusion AB.

Provide ROIC
for Xvivo Perfusion AB.

Provide ROCE
for Xvivo Perfusion AB.

Provide Gross Margin
for Xvivo Perfusion AB.

Provide Operating Margin
for Xvivo Perfusion AB.

Provide Net Margin
for Xvivo Perfusion AB.

Provide FCF Margin
for Xvivo Perfusion AB.

Show all solvency ratios
for Xvivo Perfusion AB.

Provide D/E Ratio
for Xvivo Perfusion AB.

Provide D/A Ratio
for Xvivo Perfusion AB.

Provide Interest Coverage Ratio
for Xvivo Perfusion AB.

Provide Altman Z-Score Ratio
for Xvivo Perfusion AB.

Provide Quick Ratio
for Xvivo Perfusion AB.

Provide Current Ratio
for Xvivo Perfusion AB.

Provide Cash Ratio
for Xvivo Perfusion AB.

What is the historical Revenue growth
over the last 5 years for Xvivo Perfusion AB?

What is the historical Net Income growth
over the last 5 years for Xvivo Perfusion AB?

What is the current Free Cash Flow
of Xvivo Perfusion AB?

Discuss the annual earnings per share (EPS)
trend over the past five years for Xvivo Perfusion AB.

P/B
Price to Book Value

6.8

Current

5.4

Median

2.2

Industry

Higher than median

Higher than industry value

Price to Book Value (P/B) ratio is a valuation multiple that measures the market's valuation of a company relative to its book value. The P/B ratio is only considered useful in practice when applied to capital-intensive businesses.

P/B

6.8

Market Cap

14.2B SEK

Book Value of Equity

2.1B SEK

All Countries

Forward Multiples

			Market Cap	P/B
SE		Xvivo Perfusion AB STO:XVIVO	14.2B SEK	6.8
JP		Hoya Corp TSE:7741	6.8T JPY	6.7
CH		Alcon AG SIX:ALC	37.9B CHF	2
DK		Coloplast A/S CSE:COLO B	200.9B DKK	11.2
US		Align Technology Inc NASDAQ:ALGN	16.9B USD	4.3
KR	H	HLB Inc KOSDAQ:028300	9.9T KRW	18.8
CA		Bausch + Lomb Corp NYSE:BLCO	6.9B USD	1
CN		Shenzhen New Industries Biomedical Engineering Co Ltd SZSE:300832	48.6B CNY	6.4
US		Lantheus Holdings Inc NASDAQ:LNTH	6.3B USD	5.3
US		Merit Medical Systems Inc NASDAQ:MMSI	6.1B USD	4.6
UK		ConvaTec Group PLC LSE:CTEC	4.8B GBP	3.7


SE		Xvivo Perfusion AB STO:XVIVO	Average P/B: 6.4 6.8
JP		Hoya Corp TSE:7741	6.7
CH		Alcon AG SIX:ALC	2
DK		Coloplast A/S CSE:COLO B	11.2
US		Align Technology Inc NASDAQ:ALGN	4.3
KR	H	HLB Inc KOSDAQ:028300	18.8
CA		Bausch + Lomb Corp NYSE:BLCO	1
CN		Shenzhen New Industries Biomedical Engineering Co Ltd SZSE:300832	6.4
US		Lantheus Holdings Inc NASDAQ:LNTH	5.3
US		Merit Medical Systems Inc NASDAQ:MMSI	4.6
UK		ConvaTec Group PLC LSE:CTEC	3.7

P/B Forward Multiples

Forward P/B multiple is a version of the P/B ratio that uses forecasted equity for the P/B calculation. 1-Year, 2-Years, and 3-Years forwards use equity forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward

P/B

N/A

2-Years Forward

P/B

N/A

3-Years Forward

P/B

N/A

Xvivo Perfusion AB
STO:XVIVO

P/B
Price to Book Value

P/B Forward Multiples

See Also

Company

Help

Tools

Stocks

Xvivo Perfusion AB STO:XVIVO

P/B Price to Book Value

P/B Forward Multiples

See Also

Company

Help

Tools

Stocks

Xvivo Perfusion AB
STO:XVIVO

P/B
Price to Book Value